Molecular Partners AG(US:MOLN) Globenewswire·2026-02-26 06:00Core Insights - Molecular Partners AG is a clinical-stage biotech company focused on developing DARPin therapeutics, a new class of custom-built protein drugs [5] - The company will present at two upcoming investor conferences and release its full-year 2025 financial report on March 12, 2026 [1][4] Conference Details - Molecular Partners will participate in the TD Cowen 46th Annual Health Care Conference in Boston, MA from March 2-4, 2026, with CEO Patrick Amstutz scheduled for a fireside chat on March 2 [2] - The company will also attend the Leerink Partners Global Healthcare Conference in Miami, FL from March 9-11, 2026, where CEO Patrick Amstutz will have a fireside chat on March 9 [3] Financial Reporting - The full-year 2025 financial results will be announced on March 12, 2026, at 4:00 PM EDT [4]